|
SD169
- 品牌：MedKoo
- 產(chǎn)地：美國(guó)
- 貨號(hào)：563547
- cas：1670-87-7
- 發(fā)布日期： 2022-07-20
- 更新日期： 2024-08-12
產(chǎn)品詳請(qǐng)
| 產(chǎn)地 | 美國(guó) |
| 品牌 | MedKoo |
| 貨號(hào) | 563547 |
| 用途 | This product is for research use only, not for human or veterinary use. |
| 包裝規(guī)格 | 5.0mg; 10.0mg; 25.0mg; |
| CAS編號(hào) | 1670-87-7 |
| 純度 | >98%% |
| 是否進(jìn)口 | 是 |
中文名稱:1H-吲哚-5-甲酰胺
中文別名:吲哚-5-甲酰胺
CAS No:1670-87-7
分子式:C9H8N2O
沸點(diǎn):457.624°C at 760 mmHg
閃光點(diǎn):230.563°C
折射率:1.717
密度:1.328
用途:SD 169 is a selective ATP competitive inhibitor of the MAP kinases p38α (IC50 = 3.2 nM) and p38β (IC50 = 122 nM). It has no inhibitory effect against a panel of other kinases, including p38γ MAP kinase, ERK2, JNK-1, and MAPKAPK-2, when tested in vitro at 50 μM. SD 169 is orally active, significa..
安全說(shuō)明:S26
中文別名:吲哚-5-甲酰胺
CAS No:1670-87-7
分子式:C9H8N2O
沸點(diǎn):457.624°C at 760 mmHg
閃光點(diǎn):230.563°C
折射率:1.717
密度:1.328
用途:SD 169 is a selective ATP competitive inhibitor of the MAP kinases p38α (IC50 = 3.2 nM) and p38β (IC50 = 122 nM). It has no inhibitory effect against a panel of other kinases, including p38γ MAP kinase, ERK2, JNK-1, and MAPKAPK-2, when tested in vitro at 50 μM. SD 169 is orally active, significa..
安全說(shuō)明:S26
相關(guān)產(chǎn)品：
